Ring Therapeutics Announces Presentations at the 27th Annual American Society of Gene and Cell Therapy

Development of a new class of viral vectors – Anellovectors – with potential to deliver DNA payloads across broad tissue types in redosable manner 

Anellovectors demonstrate expanded payload capacity and expression of therapeutic relevancy in retina of non-human primates

Cambridge, Mass. April 22, 2024 — Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize genetic medicines with its commensal virome platform, today announced an oral presentation and two poster presentations at the 27^th Annual American Society of Gene & Cell Therapy (ASGCT) Conference, to be held in Baltimore, Maryland from May 7 – 11, 2024. These presentations showcase the immense promise of a new class of viral vectors from Ring’s Anellogy^TM platform to overcome some of the largest barriers associated with delivery of current genetic medicines including redosability and tissue tropism.

Oral Presentation details below:

Title: Anellovectors, a Gene Delivery Platform Based on Commensal Human Anelloviruses, Have the Potential to Evade the Immune System and Deliver DNA Payloads to a Broad Range of Tissues in a Redosable Manner

Speaker: Chris Wright, MD, PhD, Chief Medical Officer at Ring Therapeutics

Session Title and Location: Emerging Viral Vectors – Ballroom 4, Baltimore Convention Center

Presentation Date and Time: Thurs, May 9, 5:00 – 5:15 PM ET

Poster Presentation details below:

Title: Anellovectors: Expanding the Payload Capacity of Anellovirus-Based Vectors Beyond the Wild-Type Genome Capacity

Abstract Number:  450

Presenter: Cato Prince

Presentation Location, Date, and Time: Exhibit Hall, Wed, May 8, 12:00 PM ET

 

Title: Anellovector Derived from Human Retinal Pigment Epithelium Delivers and Expresses a Therapeutically Relevant DNA Payload in the Retina of Nonhuman Primates

Abstract Number: 444

Presenter: Parmi Thakker

Presentation Location, Date, and Time: Exhibit Hall, Wed, May 8, 12:00 PM ET